✦ LIBER ✦

Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial

✍ Scribed by White, Darrell J.; Bahlis, Nizar J.; Marcellus, Deb C.; Belch, Andrew; Stewart, A. Keith; Chen, Christine; Kovacs, Michael J.; Macdonald, David A.; Reece, Donna E.; Reiman, Tony; Harnett, Erica; Meyer, Ralph M.; Chapman, Judy-Anne W.; Couban, Stephen

Book ID: 122456103
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 274 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2012.08.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon alfa-2b/melphalan/prednisone

Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I–II trial

✍ M. Robert Cooper; Alexander Fefer; John Thompson; Delvyn C. Case; Raymond Kempf; 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 419 KB

Interferon alfa-2b (Intron A; Schering Plough) has been shown to be active in advanced previously treated multiple myeloma (MM). Recent in vitro evidence has suggested synergy between cytotoxic agents and interferon alfa-2b. This phase I-II protocol was initiated to study interferon alfa-2b in combi

Bortezomib Plus Melphalan and Prednisone

Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial

✍ Mateos, M. V.; Richardson, P. G.; Schlag, R.; Khuageva, N. K.; Dimopoulos, M. A. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 493 KB

“Short Course” Bortezomib plus Melphalan

“Short Course” Bortezomib plus Melphalan and Prednisone as Induction Prior to Transplant or as Frontline Therapy for Nontransplant Candidates in Patients with Previously Untreated Multiple Myeloma

✍ Cristina Gasparetto; Jon P. Gockerman; Louis F. Diehl; Carlos M. de Castro; Jose 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Enoxaparin or aspirin for the prevention

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide

✍ A. PALUMBO; C. RUS; J. B. ZELDIS; F. RODEGHIERO; M. BOCCADORO; THE ITALIAN MULTI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

A Randomized Phase II Trial of Fludarabi

A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma

✍ Bashir, Qaiser; Khan, Hassan; Thall, Peter F.; Liu, Ping; Shah, Nina; Kebriaei, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Phase I/II trial assessing bendamustine

Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma

✍ Berenson, James R.; Yellin, Ori; Bessudo, Alberto; Boccia, Ralph V.; Noga, Steph 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB